AUPH
NASDAQ · Biotechnology
Aurinia Pharmaceuticals Inc
$16.41
+0.20 (+1.23%)
Open$16.21
Previous Close$16.21
Day High$16.58
Day Low$16.16
52W High$19.25
52W Low$13.33
Volume—
Avg Volume968.1K
Market Cap2.19B
P/E Ratio6.97
EPS$2.29
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+147.7% upside
Current
$16.41
$16.41
Target
$40.64
$40.64
$34.07
$40.64 avg
$61.77
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 272.30M | 212.22M | 554.79M |
| Net Income | 276.29M | 193.80M | -143,878,553 |
| Profit Margin | 101.5% | 96.4% | -25.9% |
| EBITDA | 119.63M | 88.57M | -183,212,536 |
| Free Cash Flow | — | — | -112,933,113 |
| Rev Growth | +28.3% | +28.3% | +6.7% |
| Debt/Equity | 0.12 | 0.12 | 0.45 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |